Comparative study of neoadjuvant chemotherapy before radical hysterectomy and radical surgery alone in stage IB2-IIA bulky cervical cancer

Journal of Gynecologic Oncology

Volumn 20, Issue 1, 2009, Pages 22-27

  Cho, Yun Hyun ^a   Kim, Dae Yeon ^a   Kim, Jong Hyeok ^a   Kim, Yong Man ^a   Kim, Young Tak ^a   Nam, Joo Hyun ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Locally advanced cervical cancer; Neoadjuvant chemotherapy; Radical hysterectomy

Indexed keywords

CARBOPLATIN; CISPLATIN; PACLITAXEL;

ADULT; ARTICLE; BLOOD TRANSFUSION; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; LYMPH VASCULAR SPACE INVASION; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERATION DURATION; OVERALL SURVIVAL; PELVIS LYMPHADENECTOMY; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE TREATMENT; PROGNOSIS; RADICAL HYSTERECTOMY; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR VOLUME; UTERINE CERVIX CANCER;

EID: 70449536082     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2009.20.1.22     Document Type: Article

References (31)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827-41.
2. Alvarez RD, Soong SJ, Kinney WK, Reid GC, Schray ME Podratz KC, et al. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol 1989; 35: 130-5.
3. Perez CA, Grigsby PW, Nene SM, Camel HM, Galakatos A, Kao MS, et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 1992; 69: 2796-806.
4. Thorns WW Jr, Eifel PJ, Smith TL, Morris M, Delclos L, Wharton JT, et al. Bulky endocervical carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys 1992; 23: 491-9.
5. Kim DS, Moon H, Kim KT, Hwang YY, Cho SH, Kim SR. Two-year survival: preoperative adjuvant chemotherapy in the treatment of cervical cancer stages Ib and II with bulky tumor. Gynecol Oncol 1989; 33: 225-30.
6. Friedlander ML, Atkinson K, Coppleson JV, Elliot P Green D, Houghton R, et al. The integration of chemotherapy into the management of locally advanced cervical cancer: a pilot study. Gynecol Oncol 1984; 19: 1-7.
7. Sardi J, Sananes C, Giaroli A, Bayo J, Rueda NG, Vigbi S, et al. Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB bulky, squamous carcinoma of the cervix. Gynecol Oncol 1993; 49: 156-65.
8. Hwang YY, Moon H, Cho SH, Kim KT, Moon YJ, Kim SR, et al. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol 2001; 82: 88-93.
9. Scarabelli C, Zarrelli A, Gallo A, Visentin MC. Multimodal treatment with neoadjuvant intraarterial chemotherapy and radical surgery in patients with stage IIIB-IVA cervical cancer: a preliminary study. Cancer 1995; 76: 1019-26.
10. Park SY, Kim BG, Kim JH, Lee JH, Lee ED, Lee KH, et al. Phase I/II study of neoadjuvant intraarterial chemotherapy with mitomycin-C, vincristine, and cisplatin in patients with stage IIb bulky cervical carcinoma. Cancer 1995; 76: 814-23.
11. Giaroli A, Sananes C, Sardi JE, Maya AG, Bastardas ML, Snaidas L, et al. Lymph node metastases in carcinoma of the cervix uteri: Response to neoadjuvant chemotherapy and its impact on survival. Gynecol Oncol 1990; 39: 34-9.
12. Yamakawa Y, Fujimura M, Hidaka T, Hori S, Saito S. Neoadjuvant intraarterial infusion chemotherapy in patients with stage IB2-IIIB cervical cancer. Gynecol Oncol 2000; 77: 264-70.
13. Benedetti-Panici P, Greggi S, Colombo A, Amoroso M, Smaniotto D, Giannarelli D, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol 2002; 20: 179-88.
14. Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer 2003; 39: 2470-86.
15. Eddy GL, Bundy BN, Creasman WT, Spirtos NM, Mannel RS, Hannigan E, et al. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: A phase III trial of the gynecologic oncology group. Gynecol Oncol 2007; 106: 362-9.
16. Kim DS, Moon H, Hwang YY, Cho SH. Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib, IIa, and IIb with bulky tumor. Gynecol Oncol 1988; 29: 321-32.
17. Weiner SA, Aristizabal S, Alberts DS, Surwit EA, Deatherage-Deuser K. A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma. Gynecol Oncol 1988; 30:1-6.
18. Behtash N, Nazari Z, Ayatollahi H, Modarres M, Ghaemmaghami F, Mousavi A. Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB-IIA cervical cancer. Eur J Surg Oncol 2006; 32: 1226-30.
19. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-16.
20. Piver MS, Chung WS. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol 1975; 46: 507-10.
21. Fuller AF, Elliott N, Kosloff C, Lewis JL. Lymph node metastases from carcinoma of the cervix, stages IB and IIA: implications for prognosis and treatment. Gynecologic Oncology 1982; 13: 165-74.
22. Mohar A, Frias-Mendivil M. Epidemiology of cervical cancer. Cancer Invest 2000; 18: 584-90.
23. Delgado G, Bundy BN, Fowler WC Jr, Stehman FB, Sevin B, Creasman WT, et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol 1989; 35: 314-20.
24. Modarress M, Maghami FQ, Golnavaz M, Behtash N, Mousavi A, Khalili GR. Comparative study of chemoradiation and neoadjuvant chemotherapy effects before radical hysterectomy in stage IB-IIB bulky cervical cancer and with tumor diameter greater than 4 cm. Int J Gynecol Cancer 2005; 15: 483-8.
25. Kigawa J, Minagawa Y, Ishihara H, Itamochi H, Kanamori Y, Terakawa N. The role of neoadjuvant intraarterial infusion chemotherapy with cisplatin and bleomycin for locally advanced cervical cancer. Am J Clin Oncol 1996; 19: 255-9.
26. Namkoong SE, Park JS, Kim JW, Bae SN, Han GT; Lee JM, et al. Comparative study of the patients with locally advanced stages I and II cervical cancer treated by radical surgery with and without preoperative adjuvant chemotherapy. Gynecol Oncol 1995; 59: 136-42
27. Paladini D, Raspagliesi F, Fontanelli R, Ntousias V. Radical surgery after induction chemotherapy in locally advanced cervical cancer: a feasibility study. Int J Gynecol Cancer 1995; 5: 296-300.
28. Panici PB, Scambia G, Baiocchi G, Greggi S, Ragusa G, Gallo A, et al. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer: prognostic factors for response and survival. Cancer 1991; 67: 372-9.
29. Eddy GL, Manetta A, Alvarez RD, Williams L, Creasman WT. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer. a Gynecologic Oncology Group pilot study. Gynecol Oncol 1995; 57: 412-6.
30. Huang HJ, Chang TC, Hong JH, Tseng CJ, Chou HH, Huang KG, et al. Prognostic value of age and histologic type in neoadjuvant chemotherapy plus radical surgery for bulky (>/=4 cm) stage IB and IIA cervical carcinoma. Int J Gynecol Cancer 2003; 13: 204-11.
31. Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez-Enciso A, Cetina L, Rivera L, Mariscal I, et al. A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Ann Oncol 2003; 14:1278-84.